Henriette Nielsen
EVP & Chief Transformation OFC · Keenova Therapeutics plc
- 2025
- Feb 27, 2026
- 2
Summary
Latest filing:
Henriette Nielsen has 2 SEC Form 4 filings on record going back to 2025, most recently on 27 February 2026.
Trading pattern
InsiderAlpha's records for Henriette Nielsen go back to 2025: 2 primary Form 4 filings, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Most active insiders across the market
Henriette Nielsen has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- Mauad Bruno Sousa - $189.07M in AUGO purchases and sales in the last 90 days
- Nathan Blecharczyk - $188.66M in ABNB purchases and sales in the last 90 days
- Conifer Management, L.L.C. - $187.26M in GPI purchases and sales in the last 90 days
- David A. Duffield - $186.00M in WDAY purchases and sales in the last 90 days
- Control Empresarial de Capitales S.A. de C.V. - $177.80M in PBF purchases and sales in the last 90 days
- J.H. Whitney Equity Partners VII, LLC - $169.58M in AVAH purchases and sales in the last 90 days
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Henriette Nielsen?
Henriette Nielsen is a corporate insider, tracked as EVP & Chief Transformation OFC. InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Henriette Nielsen last file a Form 4?
The most recent primary Form 4 on record is dated 27 February 2026, one of 2 filings going back to 2025.
Learn more
No Form 4 transactions on record for Henriette Nielsen yet.
Filings appear here automatically as they arrive from SEC EDGAR.